These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


382 related items for PubMed ID: 27440205

  • 21. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M, Yoshida M, Tsunematsu T, Ogawa I, Sasahira T, Kuniyasu H, Imoto I, Abiko Y, Xu D, Fukunaga S, Tahara H, Kudo Y, Nagao T, Takata T.
    Oncotarget; 2016 Feb 16; 7(7):8223-39. PubMed ID: 26882562
    [Abstract] [Full Text] [Related]

  • 22. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
    Panvongsa W, Siripoon T, Worakitchanon W, Arsa L, Trachu N, Jinawath N, Ngamphaiboon N, Chairoungdua A.
    Cancer Sci; 2021 Oct 16; 112(10):4257-4269. PubMed ID: 34273216
    [Abstract] [Full Text] [Related]

  • 23. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
    Yang M, Liu R, Sheng J, Liao J, Wang Y, Pan E, Guo W, Pu Y, Yin L.
    Oncol Rep; 2013 Jan 16; 29(1):169-76. PubMed ID: 23124769
    [Abstract] [Full Text] [Related]

  • 24. Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma.
    Koma A, Asai S, Minemura C, Oshima S, Kinoshita T, Kikkawa N, Koshizuka K, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
    Int J Mol Sci; 2021 Sep 14; 22(18):. PubMed ID: 34576110
    [Abstract] [Full Text] [Related]

  • 25. Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing.
    Chen Y, Liu M, Jin H, Peng B, Dai L, Wang S, Xing H, Wang B, Wu Z.
    Biomed Res Int; 2021 Sep 14; 2021():6529255. PubMed ID: 34485523
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA alterations in head and neck squamous cell carcinoma.
    Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, Shan S, Westra W, Sidransky D, Califano JA.
    Int J Cancer; 2008 Dec 15; 123(12):2791-7. PubMed ID: 18798260
    [Abstract] [Full Text] [Related]

  • 27. MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma.
    Hess AK, Müer A, Mairinger FD, Weichert W, Stenzinger A, Hummel M, Budach V, Tinhofer I.
    Eur J Cancer; 2017 May 15; 77():3-12. PubMed ID: 28347920
    [Abstract] [Full Text] [Related]

  • 28. Identification of miR-199-5p and miR-199-3p Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma.
    Tanaka N, Minemura C, Asai S, Kikkawa N, Kinoshita T, Oshima S, Koma A, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
    Genes (Basel); 2021 Nov 27; 12(12):. PubMed ID: 34946859
    [Abstract] [Full Text] [Related]

  • 29. Expression of microRNAs in basal cell carcinoma.
    Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.
    Br J Dermatol; 2012 Oct 27; 167(4):847-55. PubMed ID: 22540308
    [Abstract] [Full Text] [Related]

  • 30. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.
    Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y.
    J Cancer Res Clin Oncol; 2011 Apr 27; 137(4):557-66. PubMed ID: 20508945
    [Abstract] [Full Text] [Related]

  • 31. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.
    Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y, Seki N.
    Cancer Sci; 2017 Aug 27; 108(8):1681-1692. PubMed ID: 28612520
    [Abstract] [Full Text] [Related]

  • 32. MIR-107, MIR-223-3P and MIR-21-5P Reveals Potential Biomarkers in Penile Cancer.
    Pinho JD, Silva GEB, Teixeira Júnior AAL, Belfort MRC, Mendes JM, Cunha IWD, Quintana LG, Calixto JRR, Nogueira LR, Coelho RWP, Khayat AS.
    Asian Pac J Cancer Prev; 2020 Feb 01; 21(2):391-397. PubMed ID: 32102516
    [Abstract] [Full Text] [Related]

  • 33. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT, Karanam NK, Ding L, Saha D, Yordy JS, Giri U, Heymach JV, Story MD.
    Neoplasia; 2019 Sep 01; 21(9):849-862. PubMed ID: 31325708
    [Abstract] [Full Text] [Related]

  • 34. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
    Qiang H, Zhan X, Wang W, Cheng Z, Ma S, Jiang C.
    Cancer Biother Radiopharm; 2019 Apr 01; 34(3):189-195. PubMed ID: 30628842
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of the tumour-adjacent tissue in head and neck cancers.
    Raudenska M, Sztalmachova M, Gumulec J, Fojtu M, Polanska H, Balvan J, Feith M, Binkova H, Horakova Z, Kostrica R, Kizek R, Masarik M.
    Tumour Biol; 2015 Dec 01; 36(12):9929-39. PubMed ID: 26168959
    [Abstract] [Full Text] [Related]

  • 36. MicroRNA expression in differentially metastasizing tumors of the head and neck: adenoid cystic versus squamous cell carcinoma.
    Veit JA, Scheckenbach K, Schuler PJ, Laban S, Wiggenhauser PS, Thierauf J, Klussmann JP, Hoffmann TK.
    Anticancer Res; 2015 Mar 01; 35(3):1271-7. PubMed ID: 25750274
    [Abstract] [Full Text] [Related]

  • 37. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
    Liu C, Yu Z, Huang S, Zhao Q, Sun Z, Fletcher C, Jiang Y, Zhang D.
    EBioMedicine; 2019 Dec 01; 50():135-143. PubMed ID: 31780396
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
    Severino P, Brüggemann H, Andreghetto FM, Camps C, Klingbeil Mde F, de Pereira WO, Soares RM, Moyses R, Wünsch-Filho V, Mathor MB, Nunes FD, Ragoussis J, Tajara EH.
    BMC Cancer; 2013 Nov 09; 13():533. PubMed ID: 24209638
    [Abstract] [Full Text] [Related]

  • 39. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
    Sun G, Cao Y, Wang P, Song H, Bie T, Li M, Huai D.
    Biomarkers; 2018 Mar 09; 23(2):137-141. PubMed ID: 28135849
    [Abstract] [Full Text] [Related]

  • 40. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas.
    Sannigrahi MK, Sharma R, Singh V, Panda NK, Rattan V, Khullar M.
    Clin Cancer Res; 2017 Jul 15; 23(14):3884-3895. PubMed ID: 28143871
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.